Search
About Us
Enzymotec
Our Mission
Segments
Locations
Strategic partners
Management
Board of Directors
About Us  >  Strategic partners

Strategic partners

Enzymotec strategic partners are leading pharmaceutical companies and leading nutrition firms.
In 2008 Enzymotec has incorporated Advanced Lipids, a Joint Venture with AAK from Sweden. The JV is promoting products for the infant formula industry.
In 2008 Enzymotec established a Joint Venture with Elder pharmaceuticals India to launch Enzymotec's Orthomolecular Medicine concept in India.
In 2009 Enzymotec signed a cooperation agreement with DKSH International Ltd. regarding the global supply of Enzymotec's APIs and biofunctional products to pharma industry.

Teva Launches Generic Prometrium Teva Pharmaceutical Industries has a license agreement to sell Vaya Pharma products in Israel: Vayarol™ (Phyto-Guard), Vayarin™ (Zoom), and Vayacog™.
PFM medical singapore has a license agreement to sell Vayarol™, in Singapore and Malaysia.

Daiichi Sankyo, Inc. has a license agreement to sell Vayarol™ in Brazil.

Sechang Int'l Corp. has an agent agreement to sell Vaya Pharma products in South Korea: Vayarol™, Vayarin™, and Vayacog™.
  Home Page | Site Map | Contact Us  
Signed by CDTech - Web Development and Design  
Disclaimer: These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat , cure or prevent disease.
Copyright (©) 2015 Enzymotec Ltd. All rights reserved.